Warning the combination of the two flu strains H5N1 AND H1N1Labor Day 281 of
December 10, 2009 Last Updated: 7:57 AM, October 12, 2009
HPAI remains concerned connection to human health. (Labor) - *
WHO began distributing influenza A/H1N1 vaccine funding, but the Health Ministry VN not willing to commit to the terms. * Recommendation: When pneumonia, influenza A/H1N1, please test. On September 12, World Health Organization (WHO) in Vietnam has announced the supply of flu vaccine ArepanrixTM (Room influenza A/H1N1) in the form of aid. WHO has received funding commitments with a total of 180 million doses of vaccine, of which 50 million doses of Glaxo Smith Kline (GSK) 100 million doses of Sanofi Pasteur.
17 countries in the western Pacific will receive vaccine financing. In particular, U.S. will provide 1.2 million doses. WHO estimated transfer vaccine from September 12 to January February 2010. However, U.S. does not have the vaccine right this time, because in terms of receiving funding, countries must commit to receive vaccine organization and distribution of vaccine inoculation closely.
Besides, if any side effects after injection, the responsibility belongs to the national implementation of injection. This reason, the Ministry of Health is not ready to commit to signing WHO.
Answer: "In the case of side effects occurred after the vaccine, who will be the main person responsible?", WHO just confirmed: Safety of the vaccine should be guaranteed from production to to the vaccine for people. Regulatory Authority of the National Register vaccine based on scientific evidence provided by the manufacturer. This is the basis to ensure that vaccines meet the standards of quality and safety and
vaccine can be distributed and vaccination in accordance with standards and procedures stricter. Until now, pandemic vaccine safety are similar to regular seasonal flu vaccine. So far, no deaths related to this vaccine in any country.
Also on September 12, Institute of Hygiene and Epidemiology Surgeons (VSDT) and Henry Jackson Foundation Fund (USA) have started the project "Research rates antibodies circulating H5N1 virus in humans in Hanoi, Thua Thien -- Hue and Tien Giang, funding more than 1.6 million, carried out from January to September 2010 now. This project aims to determine the rate of H5N1 virus infection in the serum of the community through 12,000 individual blood samples, analyzing and making blood banks. This is a study of influenza A/H5N1 biggest scale ever in Vietnam.
Dr. Nguyen Tran Hien - Director of the Institute VSDT Surgeons - said: "The surveillance results show that, in the same family in a Dien Bien, cases of influenza A/H5N1 also died, there brother influenza A/H1N1 infected patients.
In the same time, the test samples of poultry in the family, were found positive for influenza A/H5N1. Thus, the flu vaccine was conditionally to interact in the same time. So, once again to alert the recombinant strains led to a new highly pathogenic influenza, the ability to spread strength. Monitoring results show that influenza A/H1N1, almost 100% of patients with influenza is influenza vaccine H1/N1.
MA Nguyen Hong Ha - Deputy Director of Infectious Diseases QG BV - recommended: Currently influenza A/H1N1 tests but do not make mass, but the pneumonia cases, screening tests should immediately A/H1N1 influenza .
http://www.laodong.com.vn/Home/Canh-...166549.laodong